Except for methylation, another classic mechanism of protein inactivation is a truncating gene mutation, but that does not seem to play a role in prostate carcinoma, as HNF1B mutations are a rare event in this type of tumor. This evidence concerns the gene HNF1B and prostate carcinoma.